In addition, HER3 is frequently co-expressed with HER2 in breast cancer, and high levels of HER2/HER3 dimerization are associated with poor survival prognosis in HER2-overexpressing breast cancer [15]. The gene discussed is ERBB2; the disease is breast cancer.